Astec Lifesciences Limited - Board Meeting Intimation for Approval And Adoption Of Standalone & Consolidated Audited Financial Results For The Quarter & Financial Year Ended March 31, 2019 & Consideration Of Recommendation Of Final Dividend On The Equity Shares Of The Company For The Financial Year Ended 31St March, 2019 (If Any).

ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2019 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended 31st March, 2019, after these results are reviewed by the Audit Committee and to consider recommendation of Final Dividend on the Equity Shares of the Company for the Financial Year ended 31st March, 2019 (if any). In terms of Regulation 47 of the Listing Regulations, please find enclosed herewith copies of the Notices of the Board Meeting published in newspapers, viz. Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) today, i.e., on 23rd April, 2019. Kindly take note of the above.

Pdf Link: Astec Lifesciences Limited - Board Meeting Intimation for Approval And Adoption Of Standalone & Consolidated Audited Financial Results For The Quarter & Financial Year Ended March 31, 2019 & Consideration Of Recommendation Of Final Dividend On The Equity Shares Of The Company For The Financial Year Ended 31St March, 2019 (If Any).

Source : BSE - www.bseindia.com